SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: joel3 who wrote (491)1/26/1999 5:28:00 PM
From: Jack Siegel  Read Replies (1) of 706
 
I agree, 20 does seem like a conservative order, especially given the fact that the Millennium technology is designed to replace something as common as a dental drill.

Not to rain on the parade, but it strikes me that Schein has entered into an agreement with Biolase just to get a foothold; Schein's investment in Millenium 20 units will enable them, if the Millennium is accepted by the dental market, to be in place as a distributor. If it is not, the unsold units can be flipped cheaply or just taken as a loss. Given the size of the dental market, this announcement does not seem like a strong commitment.

What is going to drive the stock is not agreements with groups such as Schein, but by the doctors willing to hand over the coin for the units. Are the advantages of the Millennium worth the money? Will it increase doctor revenue? These are the more salient questions.

JS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News